Pablo G. Legorreta

Insider Reports History

Entity
Individual
Location
110 E 59 Th Street, Suite 3300, New York, NY
Signature
/s/ Todd Girolamo as Attorney-in-Fact for Pablo G. Legorreta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Pablo G. Legorreta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PROKIDNEY CORP. Director, 10%+ Owner Class B Ordinary Shares 88.1M $248M $2.82 Feb 4, 2025 Indirect
PROKIDNEY CORP. Director, 10%+ Owner Common Units in ProKidney LP 88.1M $248M $2.82 Feb 4, 2025 Indirect
PROKIDNEY CORP. Director, 10%+ Owner Common Units in ProKidney LP 88.6M $116M $1.31 Feb 5, 2024 Indirect
PROKIDNEY CORP. Director, 10%+ Owner Class A Ordinary Shares 22.6M $56.5M $2.50 Feb 4, 2025 Indirect
PROKIDNEY CORP. Director, 10%+ Owner Class A Ordinary Shares 22.6M $54.7M $2.42 Jun 13, 2024 Indirect
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner Class A ordinary shares 292K $8.05M $27.55 Dec 30, 2022 By Tata MC 35 Ltd.
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner Class A ordinary shares 63.8K $1.76M $27.55 Nov 16, 2023 Direct
Epizyme, Inc. Director, 10%+ Owner Stock Option (Right to Buy) 41K $23K $0.56 May 17, 2022 Direct
PROKIDNEY CORP. Director, 10%+ Owner Class B Ordinary Shares 88.6M Feb 5, 2024 Indirect
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner LP interests in RPI US Partners 2019, LP 2.86M Dec 31, 2022 By Legorreta Investments II LLC
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner LP interests in RPI US Partners 2019, LP 2.7M Aug 12, 2022 By Legorreta Investments LLC
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner ICAI Interests 1.01M May 12, 2023 By Legorreta Investments LLC
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner ICAI Interests 693K May 12, 2023 Direct
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner LP interests in RPI US Partners 2019, LP 147K Dec 31, 2022 By Spouse
PROKIDNEY CORP. Director, 10%+ Owner Director stock option (right to buy) 62.6K May 30, 2024 Direct
Epizyme, Inc. Director, 10%+ Owner Common Stock, par value $0.0001 0 $1.41 Aug 12, 2022 Indirect
Epizyme, Inc. Director, 10%+ Owner Restricted Stock Units 0 Aug 12, 2022 Direct
Royalty Pharma plc CEO, Chairman of the Board, Director, 10%+ Owner ICAI Interests 0 May 12, 2023 By Spouse

Insider Reports Filed by Pablo G. Legorreta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PROK PROKIDNEY CORP. Feb 4, 2025 4 $0 4 Feb 6, 2025 Director, 10%+ Owner
PROK PROKIDNEY CORP. Jun 13, 2024 1 $54.7M 4 Jun 14, 2024 Director, 10%+ Owner
PROK PROKIDNEY CORP. May 30, 2024 1 $0 4 Jun 3, 2024 Director
PROK PROKIDNEY CORP. Feb 5, 2024 4 $0 4 Feb 6, 2024 Director, 10%+ Owner
PROK PROKIDNEY CORP. Oct 30, 2023 4 $0 4 Nov 1, 2023 Director, 10%+ Owner
PROK PROKIDNEY CORP. Jun 29, 2023 1 $0 4 Jul 3, 2023 Director, 10%+ Owner
RPRX Royalty Pharma plc Jun 28, 2023 1 $3.84M 4 Jun 28, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc Jun 12, 2023 2 $2.96M 4 Jun 13, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc May 24, 2023 1 $4.84M 4 May 24, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc May 16, 2023 2 $7.68M 4 May 17, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc May 12, 2023 2 $0 4 May 15, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc Dec 31, 2022 1 $0 5 Feb 10, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc Dec 30, 2022 2 $0 4 Nov 16, 2023 CEO, Chairman of the Board, Director, 10%+ Owner
EPZM Epizyme, Inc. Aug 12, 2022 3 $0 4 Aug 16, 2022 Director, 10%+ Owner
PROK PROKIDNEY CORP. Jul 11, 2022 3 $0 4 Jul 13, 2022 Director, 10%+ Owner
PROK PROKIDNEY CORP. Jul 11, 2022 0 $0 3 Jul 13, 2022 Director, 10%+ Owner
EPZM Epizyme, Inc. May 17, 2022 2 $23K 4 May 19, 2022 Director, 10%+ Owner
EPZM Epizyme, Inc. Jan 31, 2022 1 $34M 4 Feb 1, 2022 Director, 10%+ Owner
EPZM Epizyme, Inc. Jun 11, 2021 2 $346K 4 Jun 15, 2021 Director, 10%+ Owner
RPRX Royalty Pharma plc May 7, 2021 4 $0 4 May 11, 2021 CEO, Chairman of the Board, Director
RPRX Royalty Pharma plc Jun 16, 2020 13 $0 4 Apr 15, 2022 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc Jun 15, 2020 1 $0 4/A Apr 15, 2022 CEO, Chairman of the Board, Director, 10%+ Owner
RPRX Royalty Pharma plc Jun 15, 2020 0 $0 3/A Apr 15, 2022 CEO, Chairman of the Board, Director